Gulati Ashima, Sharma Alok, Hari Pankaj, Dinda Amit K, Bagga Arvind
Department of Pediatrics, All India Institute of Medical Sciences, Teaching block, Room number 3053#, Ansari Nagar, New Delhi, 110029, India.
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Clin Exp Nephrol. 2008 Oct;12(5):348-353. doi: 10.1007/s10157-008-0053-6. Epub 2008 Apr 8.
Collapsing glomerulopathy (CG) is a clinically and pathologically distinct variant of focal segmental glomerulosclerosis (FSGS). Pathologically similar lesions have been reported in adults and children with human immuno-deficiency virus (HIV) infection. However, there is a recent interest in the recognition of this variant in the absence of HIV infection.
To evaluate the clinical presentation and outcome of our pediatric patients with idiopathic CG.
A sum of six children with idiopathic CG, aged 1-7 years at presentation, were retrospectively identified. Clinical data and renal biopsy were reviewed for all patients. Serum creatinine and estimated GFRs at presentation and last follow-up were compared using the Wilcoxon signed rank test and the risk factors for occurrence of ESRD analyzed using the Cox proportional hazard models.
Steroid-resistant nephrotic syndrome with or without azotemia was the presenting clinical finding in all the cases. The median serum creatinine values at onset and last follow-up were 1.05 and 1.25 mg/dl, respectively (p = 0.128). Following immunosuppressive therapy one patient achieved complete remission of proteinuria, and four were in partial remission. The remaining one patient did not show any change in proteinuria at 6 months of therapy. Two of the six patients progressed to end-stage renal disease within a median follow-up period of 27 months (range 14-96 months).
Collapsing glomerulopathy is an aggressive variant of focal segmental glomerulosclerosis. All patients with CG should be screened for the underlying etiology, and patients with idiopathic CG should be offered a trial of immunosuppressive therapy.
塌陷性肾小球病(CG)是局灶节段性肾小球硬化(FSGS)在临床和病理上的一种独特变异型。在成人和儿童人类免疫缺陷病毒(HIV)感染患者中曾报道过病理上类似的病变。然而,最近人们对在无HIV感染情况下识别这种变异型产生了兴趣。
评估我们儿科特发性CG患者的临床表现及预后。
回顾性确定了6例特发性CG患儿,就诊时年龄为1至7岁。对所有患者的临床资料和肾活检进行了复查。使用Wilcoxon符号秩检验比较就诊时和末次随访时的血清肌酐及估算肾小球滤过率(GFR),并使用Cox比例风险模型分析终末期肾病(ESRD)发生的危险因素。
所有病例的首发临床表现均为激素抵抗型肾病综合征,伴或不伴氮质血症。发病时和末次随访时血清肌酐的中位数分别为1.05和1.25mg/dl(p = 0.128)。免疫抑制治疗后,1例患者蛋白尿完全缓解,4例部分缓解。其余1例患者在治疗6个月时蛋白尿无变化。6例患者中有2例在中位随访期27个月(范围14 - 96个月)内进展为终末期肾病。
塌陷性肾小球病是局灶节段性肾小球硬化的一种侵袭性变异型。所有CG患者均应筛查潜在病因,特发性CG患者应接受免疫抑制治疗试验。